Federal law prohibits dispensing without prescription.
Glogau's small study of 24 patients adds weight to previous reports that botulinum toxin A can relieve Migraines. Following this serendipitous discovery by the University Of California, San Francisco professor Glogau and other researchers began to evaluate injection points and dosages that could alleviate Migraines. In fact, most of the data consists of case reports and meeting abstracts. In the first study, reported by researchers at the Michigan Head Pain and Neurological Institute in Ann Arbor and Michigan State University, a one-time dose of 25 units of botulinum toxin A injected into the muscles of the brow, forehead and side of the head, reduced the frequency of Migraines, the severity of pain, vomiting, and the use of pain medications for up to three months. A 75-unit treatment yielded Migraine relief, but also side effects like eyelid drooping.